| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.3 | 2e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |